Navigation Links
Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
Date:5/8/2013

San Francisco Bay Area, CA (PRWEB) May 08, 2013

Real Time Genomics, Inc., the genome analytics company, today announced that it had secured a $5mm investment to fund the expansion of commercial operations. The company also disclosed that two leading genome research centers at Stanford University have purchased the company’s genome analysis platform. Researchers at the Center for Computational, Evolutionary and Human Genomics and the Stanford Center for Genomics and Personalized Medicine will use the RTG platform as a component in their genome analysis framework to accelerate numerous ongoing population genetics and clinical research projects.

RTG introduced its genomics platform in February to technologists at the AGBT meeting in Marco Island, Florida and to the clinician/research community at the ACMG meeting in March. The announced investment, composed of cash and the conversion of debt, will fund sales, marketing and genomics applications development.

As part of the ongoing relationship with Stanford, RTG, led by Vice President of Genome Science Francisco De La Vega, will collaborate leading scientists in the two centers on areas of common interest.

“This financing marks an evolutionary milestone for the company where we begin to establish a strong commercial presence in the market,” said Steve Lombardi, CEO of Real Time Genomics. “This Stanford commitment demonstrates the value of our genomics platform to enable leading-edge basic and translational genetics research.”

Real Time Genomics provides analytical platforms for the interpretation of genomes and microbiomes. The platforms are designed for compatibility with raw sequence data generated from leading sequencing platforms, including Illumina, Ion Torrent, and 454. The first version of the genomics platform is the RTG Family Caller for use in family and trio studies. The Family Caller simultaneously analyzes all the genomic data from the related individuals within a patented Bayesian algorithmic framework to accurately identify all classes of variants across the individuals, analyzed in one-tenth the time of competing platforms. Full phasing of the offspring’s genomes are reported as the haplotypes of the parents are utilized in the variant calling process. The level of accuracy is sufficient to allow for the identification of de novo variants in the offspring of the families. The platform also provides application–specific callers for case-control studies and the analysis of single genomes, which will be released at a later date.

About Real Time Genomics, Inc.

Real Time Genomics (http://www.realtimegenomics.com) has a passion for genomics. The company offers software tools and applications for the extraction of unique value from genomic data. Its competency lies in applying the combination of its patented core technology, deep computational expertise in algorithms to solve problems in next generation genomic analysis, and a team of executives with extensive experience in successful genomics companies. Real Time Genomics is a private San Francisco based company backed by investment from Catamount Ventures, Lightspeed Venture Partners, and GeneValue Ltd.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10711400.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Real Time Genomics and Knome Ink Deal to Integrate and Sell the RTG Variant Platform on knoSYS100 System
2. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
3. Nimbix and Convey Partner for “The Accelerated Genomics Cloud” (TAGC) Promotion
4. Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
5. Real Time Genomics and Omicia Partner on a Platform for Integrated Genomic Analysis for Childhood Disease
6. Venter Institute-Led Team Recovers and Sequences Genome of Periodontal Pathogen from Biofilm in Hospital Sink using Single-Cell Genomics
7. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
8. Squished bug genomics: Insect goo aids biodiversity research
9. BGI-Shenzhen Completes Acquisition of Complete Genomics
10. Genomics Data Management Leader Annai Systems Offers Shortcut to Analysis
11. Real Time Genomics Announces Formation of its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... RoviSys, ... services based in Aurora, Ohio, has broken ground on a new building in ... Triangle Park area, this new location solidifies a commitment to business in the ...
(Date:5/20/2016)... ... , ... Kablooe Design, a leading provider of product design and development services ... the business. “We have worked hard to build long-term relationships,” says President and CEO, ... honor of serving their product design and development needs through the years.” , Kablooe ...
(Date:5/19/2016)... RIDGE, British Columbia , May 19, 2016 ... AdvanTec Global Innovations Inc. (AGI), based out of ... recently added Greenlane Biogas Ltd. to its existing ... 2-year contract manufacturing agreement. AFS along with its ... Technologies (ABT) is a vertically integrated industrial group ...
(Date:5/19/2016)... May 19, 2016 - I ... orale durante il 52 ° ...    - Le conclusioni dello studio indicano ... pazienti trattati, di cui il 90% presenta una d ... o più. Il settantadue per cento dei pazienti ha riscontrato ...
Breaking Biology Technology:
(Date:3/14/2016)... -- NXTD ) ("NXT-ID" or the "Company"), a ... airing of a new series of commercials on Time Warner ... st .  The commercials will air on Bloomberg TV, Fox ... Street show. --> NXTD ) ("NXT-ID" or the ... announces the airing of a new series of commercials on ...
(Date:3/11/2016)... 11, 2016 --> ... report "Image Recognition Market by Technology (Pattern Recognition), by ... by Deployment Type (On-Premises and Cloud), by Industry Vertical ... by MarketsandMarkets, the global market is expected to grow ... Billion by 2020, at a CAGR of 19.1%. ...
(Date:3/9/2016)... YORK , March 9, 2016 This ... and future states of the RNA Sequencing (RNA Seq) ... segments such as instruments, tools and reagents, data analysis, ... Analyze various segments of the RNA-Sequencing market such as ... services Identify the main factors affecting each segment and ...
Breaking Biology News(10 mins):